Development of a Questionnaire to Measure Hypervigilance for Visceral Pain
1 other identifier
observational
157
1 country
1
Brief Summary
The aim of this study is to develop and validate a questionnaire (non-invasive technique) to identify patients who are hypervigilant for noxious visceral sensations and who show a lower threshold to report pain. This questionnaire would be useful in studies investigating the role of visceral pain hypervigilance and pain sensitivity in the comorbidity of IBS with other somatic disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2008
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2010
CompletedFirst Submitted
Initial submission to the registry
July 19, 2010
CompletedFirst Posted
Study publicly available on registry
July 21, 2010
CompletedJuly 21, 2010
July 1, 2010
2.3 years
July 19, 2010
July 19, 2010
Conditions
Keywords
Eligibility Criteria
Subjects diagnosed with irritable bowel syndrome, age 18 or older, of any race or gender, will be enrolled. These subjects will be recruited from the Functional GI \& Motility Disorder's Registry of Research Participants.
You may qualify if:
- clinical diagnosis of IBS
- meets Rome III criteria for IBS
- women or men aged 18 or older
You may not qualify if:
- use of IBS-specific compounds, opiates, anticholinergics, or any drug likely to cause constipation as a side-effect
- use of analgesics for 48 hours prior to the study
- hypothyroid
- history of bowel resection except appendectomy or cholecystectomy
- psychotic disorder, major depression, substance abuse (other than tobacco)or other psychiatric condition likely to interfere with the conduct of the study
- renal disease
- patients with inflammatory or ischemic disease of the rectum
- known to be unreliable.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UNC Center for Clinical and Translational Research
Chapel Hill, North Carolina, 27599, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
William E Whitehead, PhD
University of North Carolina, Chapel Hill
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 19, 2010
First Posted
July 21, 2010
Study Start
February 1, 2008
Primary Completion
June 1, 2010
Study Completion
June 1, 2010
Last Updated
July 21, 2010
Record last verified: 2010-07